Company / Financials
PRECISION BIOSCIENCES INC Financials
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$68.7M
FY2025 · +41.0% YoY
Net Income
$7.2M
FY2025 · +111.7% YoY
Profit Margin
10.4%
FY2025 · net income / revenue
ROE
12.7%
FY2025 · return on equity
Total Assets
$154.4M
FY2025
Total Debt
-
FY2025
Equity
$56.4M
FY2025
ROA
4.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$68.7M+41.0% YoYNet Income HistoryProfit after all expenses and taxes$7.2M+111.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$26.2M+40.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$35.3M-9.7% YoYR&D Expense HistoryResearch and development spending$59.6M+11.6% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share$1.05+106.6% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$1.04+106.5% YoYShares Outstanding HistoryWeighted average diluted shares outstanding8.2M+97.0% YoY